Sangon Raises $290 Million for Life Science Tools and Services Business

Shanghai Sangon Biotech, a company that provides life science tools and services, raised $290 million from private investors in a funding that it called “strategic.” The company offers four main categories of products: 1) DNA synthesis, 2) R&D reagents and consumables, 3) genetic sequencing and 4) protein- and antibodies-related products. Founded 30 years ago, Sangon began its corporate life as a provider of oligo synthesis services, then expanded into manufacturing various life science products and increased its service offerings. The funding, which was completed in April, was led by GL Capital, a China healthcare-focused private equity firm. More details....

Share this with colleagues: